about
Attenuation of TNF-driven murine ileitis by intestinal expression of the viral immunomodulator CrmDGenetic Influences on the Development of Fibrosis in Crohn's DiseaseHepatic manifestations of non-steroidal inflammatory bowel disease therapyAdalimumab treatment in Crohn's disease: an overview of long-term efficacy and safety in light of the EXTEND trialGenetic update on inflammatory factors in ulcerative colitis: Review of the current literatureTNF-Alpha in the Locomotor System beyond Joints: High Degree of Involvement in Myositis in a Rabbit ModelGenetic dissection of the cellular pathways and signaling mechanisms in modeled tumor necrosis factor-induced Crohn's-like inflammatory bowel disease.Critical role for tumor necrosis factor alpha in controlling the number of lumenal pathogenic bacteria and immunopathology in infectious colitis.Epithelial NF-kappaB enhances transmucosal fluid movement by altering tight junction protein composition after T cell activation.Adalimumab Treatment in Biologically Naïve Crohn's Disease: Relationship with Ectopic MUC5AC Expression and Endoscopic Improvement.Biomarkers and Microscopic Colitis: An Unmet Need in Clinical Practice.The function of tumour necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease.Anti-TNF antibody treatment of Crohn's disease.Alternative medicines as emerging therapies for inflammatory bowel diseases.Lactobacillus plantarum inhibits epithelial barrier dysfunction and interleukin-8 secretion induced by tumor necrosis factor-alphaAdalimumab induction therapy for ulcerative colitis with intolerance or lost response to infliximab: an open-label study.Current status of monoclonal antibody therapy for the treatment of inflammatory bowel disease.Lipid based therapy for ulcerative colitis-modulation of intestinal mucus membrane phospholipids as a tool to influence inflammation.Clinical use of anti-TNF therapy and increased risk of infectionsSerum immune-activation potency and response to anti-TNF-α therapy in Crohn's disease.Role of TLR4/NF-κB in damage to intestinal mucosa barrier function and bacterial translocation in rats exposed to hypoxia.TNF-alpha decreases ABCA1 expression and attenuates HDL cholesterol efflux in the human intestinal cell line Caco-2Immunoregulation in the gut: success and failures in human disease.Treatment of pediatric refractory Crohn's disease with thalidomide.Ankylosing spondylitis: introductory comments on its diagnosis and treatment.Differential regulation of prostaglandin E biosynthesis by interferon-gamma in colonic epithelial cells.Secretion imbalance between tumour necrosis factor and its inhibitor in inflammatory bowel disease.Expression of lymphocyte-endothelial receptor-ligand pairs, alpha4beta7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel diseaseManaging refractory Crohn's disease: challenges and solutionsOrally administered RDP58 reduces the severity of dextran sodium sulphate induced colitis.Dichotomal role of inhibition of p38 MAPK with SB 203580 in experimental colitisIncreased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria.Hyperhomocysteinemia in ulcerative colitis is related to folate levelsFunctionally enhanced siRNA targeting TNFα attenuates DSS-induced colitis and TLR-mediated immunostimulation in mice.Biologics in inflammatory bowel disease: how much progress have we made?Effect of turmeric on colon histology, body weight, ulcer, IL-23, MPO and glutathione in acetic-acid-induced inflammatory bowel disease in ratsClinical efficacy of adalimumab in Crohn's disease: a real practice observational study in Japan.Experimental human endotoxemia: a model of the systemic inflammatory response syndrome?Certolizumab pegol, a monthly subcutaneously administered Fc-free anti-TNFalpha, improves health-related quality of life in patients with moderate to severe Crohn's disease.Mucosal IL-10 and TGF-beta play crucial roles in preventing LPS-driven, IFN-gamma-mediated epithelial damage in human colon explants.
P2860
Q24607556-F2BC6B2A-315B-4089-87BC-1C83CAAC87E9Q26745889-E1D50931-AD21-4ACC-9A88-29627FE75E19Q26773684-CDEC5482-1D2D-4AFE-9BA6-38455BD3EED5Q26829488-9827768B-B6E0-4E06-AB5B-D572C213D1AEQ26852514-5425B4CA-E6E1-4E8A-9FFC-66EFC6F631AAQ28382819-41B7FF44-2D03-4E38-A6FE-BCE3521523B0Q30310327-E8FB57B6-0F73-4BDA-B561-3C83875C5926Q33552079-6A1265D7-A4B6-45A6-94D5-5A634E44D289Q33556277-EA385B4B-BB34-4900-9A21-6005BA832A17Q33562796-DA976536-2836-4260-B21C-586AED23856AQ33653647-AB3A4DDC-F41A-405C-B79D-291C471AE050Q33782327-DA99DABA-13B2-4E39-BED4-CA6F86750876Q33782391-4475286C-ACB5-4C20-A18C-393181FFE5EDQ34069427-8A36A186-F9C9-42E4-AD91-CA40EA413FD4Q34099453-2A8D58B7-B93F-4C51-B6B4-0951B6269AFBQ34100121-3773A38E-BCBC-42A9-B334-39C3E34E3ECDQ34127277-A4F04A41-0AB3-4963-B0B4-B728DBBC9824Q34154684-7329DCA2-4212-4339-8420-2F9176A7636BQ34338096-2F965296-A261-4457-BD47-4F2C8A566E97Q34406486-A3643606-C132-486C-A9D9-70C383282F70Q34451874-4EDD5B12-BE47-4A7D-9EB7-1058F3240B85Q34559884-F205AA88-1F1C-41A3-ACE5-41A9E41A18AFQ34601009-FE956D67-7A04-4803-802C-626C2E6D18B5Q34744824-1A2A830B-2686-4AF6-A339-0984CCC7754FQ34967487-4625D357-9E5A-4F20-BF41-1E957F5D4D40Q35047018-2E7934D9-AD28-4075-8414-CC0379E9187AQ35351969-AE07C060-6474-40A8-9927-7F6391B020D0Q35357996-2D874F45-D10F-474F-99EE-1965C6A0E8C7Q35460367-F45ABBEB-0B30-407B-8982-72E92F0EA255Q35579230-E0D1D9EE-B985-404F-80CD-60EF123D56EAQ35594482-364F7D05-ED3B-428D-B045-D6079BF5AE70Q35595154-98E09E4D-C6FA-4BBA-B458-1AD86808AD90Q35621645-841A5FE7-11D3-49B6-8909-EB3A5D9555B4Q35750016-AC4948EE-52F4-41F8-80D2-4679C3BA573EQ35861158-9E5D7635-C639-4170-BBCF-20D29083D82DQ35932970-F53E2F90-FC5E-4286-B34B-1EB877259119Q36089928-52E17EF3-F1E9-4CB3-B693-C8B064BC4D66Q36415681-040ED58E-9327-4F31-8067-E51EAE0C4567Q36428382-F9FDC436-DF1D-4867-890F-3D9AD252C40DQ36439020-952F5C19-FBEC-4C32-B11B-A3607EB16A5A
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Tumour necrosis factor and Crohn's disease
@en
type
label
Tumour necrosis factor and Crohn's disease
@en
prefLabel
Tumour necrosis factor and Crohn's disease
@en
P2860
P1433
P1476
Tumour necrosis factor and Crohn's disease
@en
P2093
Van Deventer SJ
P2860
P304
P407
P577
1997-04-01T00:00:00Z